Tada Takeshi, Kusano Kengo Fukushima, Ogawa Aiko, Iwasaki Jun, Sakuragi Satoru, Kusano Isao, Takatsu Seiko, Miyazaki Masashi, Ohe Tohru
Department of Cardiology, Okayama University Graduate School of Medicine, and Fukushima Naika Clinic, Saiwaicho Memorial Hospital, Okayama, Japan.
Nephrol Dial Transplant. 2007 Apr;22(4):1190-7. doi: 10.1093/ndt/gfl748. Epub 2007 Feb 3.
Sleep apnoea (SA) is often observed in haemodialysis patients, but there have been few studies on types of SA and their predictors. We therefore investigated the prevalence and types of SA and the associations between types of SA and clinical factors in haemodialysis patients.
We initially examined nocturnal oxygen desaturation index (ODI) (desaturation of >4%/events per hour) in 119 haemodialysis patients (68 males, mean age of 61.4 years). Patients with ODI of more than five were diagnosed as having SA. Then, 30 patients underwent polysomnography and we measured Apnoea-hypopnoea index (AHI), which was calculated as the number of apnoeas plus hypopnoeas per hour of sleep. Clinical characteristics were examined in all patients.
Forty-one (34.5%) of the 119 patients had SA. Twenty-seven (22.7%) of the 119 patients had SA with subjective symptoms such as daytime somnolence and snoring. There was a significant difference between body mass index (BMI) in patients with SA and that in patients without SA (22.5 vs 19.8 kg/m2, P<0.001). There were significantly higher prevalences of hypertension (85.4 vs 66.7%, P<0.05) and diabetes mellitus (36.6 vs 10.3%, P<0.01) in patients with SA than those in patients without SA. Multivariable analysis showed that BMI was independently associated with the occurrence of SA (OR 1.20, 95% CI 1.05-1.38). Mean AHI of 30 patients who underwent polysomnography was 53.2+/-28.9 [central apnoea, 4.1+/-5.6 (8%); obstructive apnoea, 21.7+/-21.5 (42%); mixed apnoea, 4.9+/-8.0 (9%); hypopnoea, 21.4+/-15.5 (41%)]. The number of obstructive apnoea events per hour was significantly correlated with BUN (r=0.490, P<0.01), Cr (r=0.418, P<0.05) and BMI (r=0.489, P<0.01) and was inversely correlated with serum bicarbonate (r=-0.646, P<0.01) and brain natriuretic peptide (BNP) (r=-0.481, P<0.01). The number of central apnoea events per hour was correlated inversely with PaO2 (r=-0.393, P<0.05) and PaCO2 (r=-0.388, P<0.05) and tended to be correlated with cardiothoracic ratio (CTR) (r=0.347, P=0.060).
There is a high prevalence of SA in haemodialysis patients. The dominant type of SA in haemodialysis patients is obstructive sleep apnoea (OSA). Uraemia (BUN, Cr), metabolic acidosis (serum bicarbonate) and BMI are good predictors of OSA. PaO2, PaCO2 and CTR are good predictors of central sleep apnoea (CSA). Good management of these factors might improve SA in haemodialysis patients.
睡眠呼吸暂停(SA)在血液透析患者中经常被观察到,但关于SA的类型及其预测因素的研究很少。因此,我们调查了血液透析患者中SA的患病率和类型,以及SA类型与临床因素之间的关联。
我们首先检查了119例血液透析患者(68例男性,平均年龄61.4岁)的夜间氧饱和度下降指数(ODI)(每小时饱和度下降>4%/事件)。ODI超过5的患者被诊断为患有SA。然后,30例患者进行了多导睡眠图检查,我们测量了呼吸暂停低通气指数(AHI),其计算方法为每小时睡眠中的呼吸暂停次数加上低通气次数。对所有患者的临床特征进行了检查。
119例患者中有41例(34.5%)患有SA。119例患者中有27例(22.7%)患有SA并伴有白天嗜睡和打鼾等主观症状。SA患者与非SA患者的体重指数(BMI)存在显著差异(22.5 vs 19.8 kg/m2,P<0.001)。SA患者的高血压患病率(85.4% vs 66.7%,P<0.05)和糖尿病患病率(36.6% vs 10.3%,P<0.01)显著高于非SA患者。多变量分析显示,BMI与SA的发生独立相关(OR 1.20,95%CI 1.05-1.38)。30例接受多导睡眠图检查的患者的平均AHI为53.2±28.9[中枢性呼吸暂停,4.1±5.6(8%);阻塞性呼吸暂停,21.7±21.5(42%);混合性呼吸暂停,4.9±8.0(9%);低通气,21.4±(41%)]。每小时阻塞性呼吸暂停事件数与血尿素氮(BUN)(r=0.490,P<0.01)、肌酐(Cr)(r=0.418,P<0.05)和BMI(r=0.489,P<0.01)显著相关,与血清碳酸氢盐(r=-0.646,P<0.01)和脑钠肽(BNP)(r=-0.481,P<0.01)呈负相关。每小时中枢性呼吸暂停事件数与动脉血氧分压(PaO2)(r=-0.393,P<0.05)和动脉血二氧化碳分压(PaCO2)(r=-0.388,P<0.05)呈负相关,且与心胸比率(CTR)有相关性趋势(r=0.347,P=0.060)。
血液透析患者中SA的患病率很高。血液透析患者中SA的主要类型是阻塞性睡眠呼吸暂停(OSA)。尿毒症(BUN、Cr)、代谢性酸中毒(血清碳酸氢盐)和BMI是OSA的良好预测指标。PaO2、PaCO2和CTR是中枢性睡眠呼吸暂停(CSA)的良好预测指标。对这些因素进行良好管理可能会改善血液透析患者的SA情况。